The lawsuits center on sudden vision loss, a possible link researchers have been studying in weight loss drugs for several years.
Recap by typeshit. Full story at Moneywise on MSN.
A man says Mounjaro and Trulicity caused his gastroparesis, and the clip walks through who must warn patients about side effects under Indiana law.
Alicia Butterfield claims Anthem denied her Zepbound once the drug got her below morbid obesity. A Los Angeles judge stayed her case pending arbitration.
STAT
Members of Congress from both parties want the FDA to stop imports of copycat versions of Eli Lilly's experimental obesity drug, which is still in trials.
The advisory covers a 30 mg multi-use tirzepatide vial sold with bacteriostatic water, and tells people not to buy or use the unregistered product.
Medscape asks if Eli Lilly's experimental triple-acting drug could help patients who stall on current GLP-1 treatments. Few details are given beyond the headline.
Good Morning America looks at GLP-1 use spreading from adults to a growing number of teens being treated for obesity.
Loading…